The DC activity also seems deficient within TME since the methylation pattern of CD40 promoter indicates that the CD40 surface molecule, fundamental for inducing adaptive immunity, is epigenetically silenced in IBC, especially in cold tumors. This evidence concerns the gene CD40 and inflammatory breast carcinoma.